Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proline-rich protein 21 pseudogene (ENSG00000260610, LOC100419016) is a nonfunctional genomic locus in humans with strong sequence similarity to the functional proline-rich protein 21 (PRR21) gene. Pseudogenes, by definition, are segments of DNA that resemble known genes but contain disabling mutations and generally do not produce a functional protein product. There is no evidence that this pseudogene encodes a protein or has any specific biological function, disease association, or therapeutic relevance. Pseudogenes commonly arise by gene duplication or retrotransposition, and their biological impact is usually limited, although in some cases pseudogenes may contribute to gene regulation through noncoding RNA mechanisms. This entry should not be considered a current or plausible drug target. If you are seeking a functional protein, the relevant entity is likely "Proline-rich protein 21" (PRR21), not the pseudogene. Pseudogenes are frequently annotated in genomic resources, but unless specifically shown to play a regulatory or structural role (such as acting as a non-coding RNA with biological function), they are not classified as molecular targets for drug or biomarker development. No data indicate any role for "proline rich 21 pseudogene" in disease, therapy, or as a marker in clinical contexts. This entry is most accurately classified as incorrect as a drug target because it is not a protein-coding gene, nor is it associated with any defined mechanism or clinical application.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline-rich protein 21 pseudogene.